Form 4/A for SMMT Summit Therapeutics Inc.
Accepted 2023-03-08 00:00:00 ET · period of report 2022-08-16 · accession 0001849682-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2023-03-08 | 2022-08-16 | SMMT | Dhingra Ankur | CFO | P - Purchase | $0.97 | +24.7K | 38.2K | +182% | +$23.9K |
| A | 2023-03-08 | 2022-08-16 | SMMT | Dhingra Ankur | CFO | P - Purchase | $0.97 | +13.0K | 39.5K | +49% | +$12.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | P | A | 24,658 | $0.97 | 38,196 | I | — | — | (F2) The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2022-08-16 | P | A | 13,027 | $0.97 | 39,527 | D By Dhingra Family Revocable Trust | — | — | (F1) This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing. |